Introducing our NEW PhysioMimix HT (Higher Throughput)
Introducing the latest microphysiological system in our PhysioMimix™ OOC range - the PhysioMimix™ Single-organ Higher Throughput (HT) System - along with the groundbreaking Multi-chip Liver-48 Plate.
Our next-generation technology overcomes three adoption limitations, cost/chip, throughput and data confidence so that you can benefit from human-relevant insights earlier than ever before.
Through the careful miniaturization of our well-characterized human liver model, which recapitulates its functionality and microarchitecture, the solution facilitates larger-scale yet cost-effective comparative drug screening. Providing 48 chips in one SBS-standard footprint, the Liver-48 plate supports in-plate replicates, controls and 7-point dose responses for data robustness/ reproducibility.
Enabling multi-plate runs per system, this highly scalable solution brings game-changing throughput for predicting human drug safety and efficacy. It can be deployed for a variety of applications, including modeling Non-alcoholic steatohepatitis (NASH), Hepatitis B, drug-induced liver injury and drug metabolism/hepatic clearance.
#organonchip #lifescience #technologynews
Видео Introducing our NEW PhysioMimix HT (Higher Throughput) канала CN Bio
Our next-generation technology overcomes three adoption limitations, cost/chip, throughput and data confidence so that you can benefit from human-relevant insights earlier than ever before.
Through the careful miniaturization of our well-characterized human liver model, which recapitulates its functionality and microarchitecture, the solution facilitates larger-scale yet cost-effective comparative drug screening. Providing 48 chips in one SBS-standard footprint, the Liver-48 plate supports in-plate replicates, controls and 7-point dose responses for data robustness/ reproducibility.
Enabling multi-plate runs per system, this highly scalable solution brings game-changing throughput for predicting human drug safety and efficacy. It can be deployed for a variety of applications, including modeling Non-alcoholic steatohepatitis (NASH), Hepatitis B, drug-induced liver injury and drug metabolism/hepatic clearance.
#organonchip #lifescience #technologynews
Видео Introducing our NEW PhysioMimix HT (Higher Throughput) канала CN Bio
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Organ-on-Chip Studies with Physiomimix OOC from CNBio (60 second walkthrough)ALL STEPSCN BIOWEBINAR: Organ on a Chip: Improving Preclinical Studies for Faster Drug DevelopmentBenchtop Organ-on-Chip Device: Physiomimix from CNBio (60 second walkthrough)Organ-on-Chip Studies Workflow Walk-Through (1/6): PhysioMimix T1 from CN BioEngineering Mucosal Barriers: From Organoids to Organs-on-ChipsTesting on Humans: Predict Hepatotoxicity and Drug Clearance Ahead of Clinical Trials Using OOCOrgan-on-Chip Studies Workflow (3/6) Dosing with PhysioMimix T1 from CN BioPhysioMimix™ OOC - Single and multi organ-on-a-chip systemsIntroducing the benefits of a human-relevant organ-on-a-chip approach to drug discovery - CN Bio.We are CN Bio - About UsPredicting the future: humanised drug evaluation testing using organ-on-a-chip technologyOrgan-on-Chip Studies Workflow (5/6) Multi-Organ Analysis with PhysioMimix T1 from CN BioThe Rhythm of Life: Using Microfluidics to Mimic Blood Flow. Single and Multi-Organ-on-a-Chip Models5 Minute Guide to Human Organ-on-Chip Studies: Cells, Tissues, Organs and Multi-Organ ExperimentsHow our PhysioMimix system (Organ-on-a-Chip) worksOrgan-on-Chip Studies Workflow (5/6) Multi-Organ Analysis with PhysioMimix OOC from CN BioGo with the Flow: Application of Microfluidic 3D Liver Chip Models for Genotoxity TestingOrgan-on-Chip Studies Workflow (2/6) Cell Culture with PhysioMimix T1 from CN Bio